nodes	percent_of_prediction	percent_of_DWPC	metapath
Hydrocodone—Muscle strain—Metformin—polycystic ovary syndrome	0.164	0.321	CcSEcCtD
Hydrocodone—Contusion—Metformin—polycystic ovary syndrome	0.0236	0.0461	CcSEcCtD
Hydrocodone—Lightheadedness—Metformin—polycystic ovary syndrome	0.0184	0.036	CcSEcCtD
Hydrocodone—Lethargy—Metformin—polycystic ovary syndrome	0.0152	0.0298	CcSEcCtD
Hydrocodone—Pain in extremity—Metformin—polycystic ovary syndrome	0.0149	0.0292	CcSEcCtD
Hydrocodone—Migraine—Metformin—polycystic ovary syndrome	0.0147	0.0287	CcSEcCtD
Hydrocodone—Dehydration—Metformin—polycystic ovary syndrome	0.0139	0.0271	CcSEcCtD
Hydrocodone—Abdominal discomfort—Metformin—polycystic ovary syndrome	0.0124	0.0242	CcSEcCtD
Hydrocodone—Upper respiratory tract infection—Metformin—polycystic ovary syndrome	0.012	0.0234	CcSEcCtD
Hydrocodone—Drowsiness—Metformin—polycystic ovary syndrome	0.0115	0.0225	CcSEcCtD
Hydrocodone—Oedema peripheral—Metformin—polycystic ovary syndrome	0.0102	0.0199	CcSEcCtD
Hydrocodone—Connective tissue disorder—Metformin—polycystic ovary syndrome	0.0101	0.0198	CcSEcCtD
Hydrocodone—Angiopathy—Metformin—polycystic ovary syndrome	0.00936	0.0183	CcSEcCtD
Hydrocodone—Mediastinal disorder—Metformin—polycystic ovary syndrome	0.0093	0.0182	CcSEcCtD
Hydrocodone—Malnutrition—Metformin—polycystic ovary syndrome	0.00898	0.0176	CcSEcCtD
Hydrocodone—Muscle spasms—Metformin—polycystic ovary syndrome	0.00864	0.0169	CcSEcCtD
Hydrocodone—Tremor—Metformin—polycystic ovary syndrome	0.00842	0.0165	CcSEcCtD
Hydrocodone—Myalgia—Metformin—polycystic ovary syndrome	0.00765	0.015	CcSEcCtD
Hydrocodone—Unspecified disorder of skin and subcutaneous tissue—Metformin—polycystic ovary syndrome	0.0076	0.0149	CcSEcCtD
Hydrocodone—Nervous system disorder—Metformin—polycystic ovary syndrome	0.00719	0.0141	CcSEcCtD
Hydrocodone—Thrombocytopenia—Metformin—polycystic ovary syndrome	0.00718	0.014	CcSEcCtD
Hydrocodone—Skin disorder—Metformin—polycystic ovary syndrome	0.00712	0.0139	CcSEcCtD
Hydrocodone—Hyperhidrosis—Metformin—polycystic ovary syndrome	0.00709	0.0139	CcSEcCtD
Hydrocodone—Hypotension—Metformin—polycystic ovary syndrome	0.00685	0.0134	CcSEcCtD
Hydrocodone—Musculoskeletal discomfort—Metformin—polycystic ovary syndrome	0.00668	0.0131	CcSEcCtD
Hydrocodone—Paraesthesia—Metformin—polycystic ovary syndrome	0.00658	0.0129	CcSEcCtD
Hydrocodone—Dyspnoea—Metformin—polycystic ovary syndrome	0.00654	0.0128	CcSEcCtD
Hydrocodone—Somnolence—Metformin—polycystic ovary syndrome	0.00652	0.0127	CcSEcCtD
Hydrocodone—Gastrointestinal disorder—Metformin—polycystic ovary syndrome	0.00633	0.0124	CcSEcCtD
Hydrocodone—Fatigue—Metformin—polycystic ovary syndrome	0.00632	0.0124	CcSEcCtD
Hydrocodone—Constipation—Metformin—polycystic ovary syndrome	0.00627	0.0123	CcSEcCtD
Hydrocodone—Gastrointestinal pain—Metformin—polycystic ovary syndrome	0.006	0.0117	CcSEcCtD
Hydrocodone—Abdominal pain—Metformin—polycystic ovary syndrome	0.0058	0.0113	CcSEcCtD
Hydrocodone—Asthenia—Metformin—polycystic ovary syndrome	0.00526	0.0103	CcSEcCtD
Hydrocodone—Pruritus—Metformin—polycystic ovary syndrome	0.00519	0.0101	CcSEcCtD
Hydrocodone—Dizziness—Metformin—polycystic ovary syndrome	0.00485	0.00948	CcSEcCtD
Hydrocodone—Vomiting—Metformin—polycystic ovary syndrome	0.00466	0.00912	CcSEcCtD
Hydrocodone—Rash—Metformin—polycystic ovary syndrome	0.00462	0.00904	CcSEcCtD
Hydrocodone—Dermatitis—Metformin—polycystic ovary syndrome	0.00462	0.00903	CcSEcCtD
Hydrocodone—Headache—Metformin—polycystic ovary syndrome	0.00459	0.00898	CcSEcCtD
Hydrocodone—Nausea—Metformin—polycystic ovary syndrome	0.00436	0.00852	CcSEcCtD
Hydrocodone—CYP3A4—Metapathway biotransformation—SULT2A1—polycystic ovary syndrome	0.000451	0.000923	CbGpPWpGaD
Hydrocodone—CYP2D6—Metapathway biotransformation—CYP19A1—polycystic ovary syndrome	0.00045	0.00092	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling by GPCR—ADRB3—polycystic ovary syndrome	0.000445	0.00091	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—PDE3B—polycystic ovary syndrome	0.000442	0.000905	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—PLEKHG5—polycystic ovary syndrome	0.000442	0.000904	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling by GPCR—LHB—polycystic ovary syndrome	0.00044	0.0009	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—ADRA1D—polycystic ovary syndrome	0.000438	0.000897	CbGpPWpGaD
Hydrocodone—OPRM1—GPCR ligand binding—GNAS—polycystic ovary syndrome	0.000434	0.000888	CbGpPWpGaD
Hydrocodone—OPRM1—GPCR downstream signaling—MTNR1B—polycystic ovary syndrome	0.000433	0.000885	CbGpPWpGaD
Hydrocodone—OPRD1—GPCR downstream signaling—GHRL—polycystic ovary syndrome	0.000431	0.000882	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling by GPCR—GNRH1—polycystic ovary syndrome	0.00043	0.000879	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—ADRA1B—polycystic ovary syndrome	0.000426	0.000872	CbGpPWpGaD
Hydrocodone—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—polycystic ovary syndrome	0.000416	0.000851	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—INHBB—polycystic ovary syndrome	0.000415	0.00085	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling by GPCR—SCT—polycystic ovary syndrome	0.000412	0.000843	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—PTGER3—polycystic ovary syndrome	0.000408	0.000835	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—LHCGR—polycystic ovary syndrome	0.000408	0.000835	CbGpPWpGaD
Hydrocodone—CYP3A4—Biological oxidations—CYP11A1—polycystic ovary syndrome	0.000405	0.000829	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—FSHR—polycystic ovary syndrome	0.000403	0.000824	CbGpPWpGaD
Hydrocodone—CYP3A4—Metapathway biotransformation—CYP11A1—polycystic ovary syndrome	0.000399	0.000817	CbGpPWpGaD
Hydrocodone—OPRD1—GPCR ligand binding—POMC—polycystic ovary syndrome	0.000394	0.000807	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling by GPCR—MTNR1B—polycystic ovary syndrome	0.000393	0.000804	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling by GPCR—GHRL—polycystic ovary syndrome	0.000392	0.000801	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—PDE3B—polycystic ovary syndrome	0.000388	0.000794	CbGpPWpGaD
Hydrocodone—OPRM1—Class A/1 (Rhodopsin-like receptors)—POMC—polycystic ovary syndrome	0.000384	0.000785	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—PTAFR—polycystic ovary syndrome	0.000382	0.000781	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—RACGAP1—polycystic ovary syndrome	0.000379	0.000775	CbGpPWpGaD
Hydrocodone—OPRK1—GPCR downstream signaling—GHRL—polycystic ovary syndrome	0.000378	0.000774	CbGpPWpGaD
Hydrocodone—CYP3A4—Metapathway biotransformation—AKR1C3—polycystic ovary syndrome	0.000377	0.000772	CbGpPWpGaD
Hydrocodone—CYP3A4—Biological oxidations—CYP17A1—polycystic ovary syndrome	0.000377	0.00077	CbGpPWpGaD
Hydrocodone—CYP3A4—Metapathway biotransformation—CYP17A1—polycystic ovary syndrome	0.000371	0.00076	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—ADRA1D—polycystic ovary syndrome	0.00037	0.000758	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—ADRA1A—polycystic ovary syndrome	0.000368	0.000754	CbGpPWpGaD
Hydrocodone—CYP2D6—Biological oxidations—CYP1A1—polycystic ovary syndrome	0.000367	0.000752	CbGpPWpGaD
Hydrocodone—CYP2D6—Metapathway biotransformation—CYP1A1—polycystic ovary syndrome	0.000362	0.000741	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—ADRA1B—polycystic ovary syndrome	0.00036	0.000737	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—FST—polycystic ovary syndrome	0.000359	0.000735	CbGpPWpGaD
Hydrocodone—OPRD1—GPCR downstream signaling—ADRB2—polycystic ovary syndrome	0.000357	0.00073	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—ADRB3—polycystic ovary syndrome	0.000355	0.000726	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—FSHR—polycystic ovary syndrome	0.000353	0.000723	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—INHBB—polycystic ovary syndrome	0.000351	0.000718	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—LHB—polycystic ovary syndrome	0.00035	0.000717	CbGpPWpGaD
Hydrocodone—OPRK1—GPCR ligand binding—POMC—polycystic ovary syndrome	0.000346	0.000708	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling by GPCR—GHRL—polycystic ovary syndrome	0.000343	0.000703	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—GNRH1—polycystic ovary syndrome	0.000343	0.000701	CbGpPWpGaD
Hydrocodone—CYP3A4—Phase 1 - Functionalization of compounds—POMC—polycystic ovary syndrome	0.000337	0.00069	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—RACGAP1—polycystic ovary syndrome	0.000332	0.000679	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—AKR1C1—polycystic ovary syndrome	0.000332	0.000679	CbGpPWpGaD
Hydrocodone—OPRD1—GPCR downstream signaling—GNAS—polycystic ovary syndrome	0.000331	0.000677	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—SCT—polycystic ovary syndrome	0.000328	0.000672	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—PDE3B—polycystic ovary syndrome	0.000328	0.000671	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling by GPCR—ADRB2—polycystic ovary syndrome	0.000324	0.000663	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—NMNAT3—polycystic ovary syndrome	0.000323	0.000661	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—ADRA1A—polycystic ovary syndrome	0.000323	0.000661	CbGpPWpGaD
Hydrocodone—OPRM1—GPCR downstream signaling—GHRL—polycystic ovary syndrome	0.00032	0.000654	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—FST—polycystic ovary syndrome	0.000315	0.000644	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—MTNR1B—polycystic ovary syndrome	0.000313	0.000641	CbGpPWpGaD
Hydrocodone—OPRK1—GPCR downstream signaling—ADRB2—polycystic ovary syndrome	0.000313	0.00064	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—ADRB3—polycystic ovary syndrome	0.000311	0.000636	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—FGF18—polycystic ovary syndrome	0.000308	0.00063	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—LHB—polycystic ovary syndrome	0.000307	0.000629	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—RBP4—polycystic ovary syndrome	0.000305	0.000625	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling by GPCR—GNAS—polycystic ovary syndrome	0.000301	0.000615	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—GNRH1—polycystic ovary syndrome	0.0003	0.000615	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—FSHR—polycystic ovary syndrome	0.000299	0.000611	CbGpPWpGaD
Hydrocodone—CYP3A4—Biological oxidations—CYP19A1—polycystic ovary syndrome	0.000298	0.00061	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—SUOX—polycystic ovary syndrome	0.000296	0.000605	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—LPCAT2—polycystic ovary syndrome	0.000296	0.000605	CbGpPWpGaD
Hydrocodone—CYP3A4—Metapathway biotransformation—CYP19A1—polycystic ovary syndrome	0.000294	0.000601	CbGpPWpGaD
Hydrocodone—OPRM1—GPCR ligand binding—POMC—polycystic ovary syndrome	0.000292	0.000598	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—AKR1C1—polycystic ovary syndrome	0.000291	0.000595	CbGpPWpGaD
Hydrocodone—OPRK1—GPCR downstream signaling—GNAS—polycystic ovary syndrome	0.00029	0.000594	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling by GPCR—GHRL—polycystic ovary syndrome	0.00029	0.000594	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—SCT—polycystic ovary syndrome	0.000288	0.000589	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—YAP1—polycystic ovary syndrome	0.000285	0.000583	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling by GPCR—ADRB2—polycystic ovary syndrome	0.000284	0.000582	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—GAB1—polycystic ovary syndrome	0.000281	0.000575	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—RACGAP1—polycystic ovary syndrome	0.000281	0.000574	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—ISYNA1—polycystic ovary syndrome	0.000275	0.000562	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—MTNR1B—polycystic ovary syndrome	0.000275	0.000562	CbGpPWpGaD
Hydrocodone—CYP2D6—Biological oxidations—POMC—polycystic ovary syndrome	0.000274	0.00056	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—ADRA1A—polycystic ovary syndrome	0.000273	0.000559	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—FGF18—polycystic ovary syndrome	0.00027	0.000552	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—INSR—polycystic ovary syndrome	0.000269	0.00055	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—RBP4—polycystic ovary syndrome	0.000268	0.000548	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—FST—polycystic ovary syndrome	0.000266	0.000544	CbGpPWpGaD
Hydrocodone—OPRM1—GPCR downstream signaling—ADRB2—polycystic ovary syndrome	0.000265	0.000541	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling by GPCR—GNAS—polycystic ovary syndrome	0.000264	0.000539	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—ADRB3—polycystic ovary syndrome	0.000263	0.000538	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—LHB—polycystic ovary syndrome	0.00026	0.000531	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—AKR1C3—polycystic ovary syndrome	0.000255	0.000523	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—GNRH1—polycystic ovary syndrome	0.000254	0.000519	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—TNRC6B—polycystic ovary syndrome	0.000251	0.000514	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—YAP1—polycystic ovary syndrome	0.00025	0.000511	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—PGR—polycystic ovary syndrome	0.000249	0.000509	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—GAB1—polycystic ovary syndrome	0.000246	0.000504	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—AKR1C1—polycystic ovary syndrome	0.000246	0.000503	CbGpPWpGaD
Hydrocodone—OPRM1—GPCR downstream signaling—GNAS—polycystic ovary syndrome	0.000245	0.000502	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—SCT—polycystic ovary syndrome	0.000243	0.000498	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling by GPCR—ADRB2—polycystic ovary syndrome	0.00024	0.000492	CbGpPWpGaD
Hydrocodone—CYP3A4—Biological oxidations—CYP1A1—polycystic ovary syndrome	0.00024	0.000491	CbGpPWpGaD
Hydrocodone—CYP3A4—Metapathway biotransformation—CYP1A1—polycystic ovary syndrome	0.000237	0.000485	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—INSR—polycystic ovary syndrome	0.000236	0.000482	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—TEAD2—polycystic ovary syndrome	0.000234	0.000478	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—AKR1C2—polycystic ovary syndrome	0.000234	0.000478	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—MTNR1B—polycystic ovary syndrome	0.000232	0.000475	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—GHRL—polycystic ovary syndrome	0.000231	0.000473	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—PLAT—polycystic ovary syndrome	0.000231	0.000473	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—FGF18—polycystic ovary syndrome	0.000228	0.000467	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—RBP4—polycystic ovary syndrome	0.000226	0.000463	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—AKR1C3—polycystic ovary syndrome	0.000224	0.000458	CbGpPWpGaD
Hydrocodone—OPRD1—GPCR downstream signaling—POMC—polycystic ovary syndrome	0.000223	0.000456	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling by GPCR—GNAS—polycystic ovary syndrome	0.000223	0.000456	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—ATF1—polycystic ovary syndrome	0.000221	0.000452	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—TNRC6B—polycystic ovary syndrome	0.00022	0.000451	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—PGR—polycystic ovary syndrome	0.000218	0.000446	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—TCF7L2—polycystic ovary syndrome	0.000215	0.00044	CbGpPWpGaD
Hydrocodone—OPRD1—GPCR downstream signaling—AKT2—polycystic ovary syndrome	0.000214	0.000438	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—NMNAT3—polycystic ovary syndrome	0.000211	0.000432	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—YAP1—polycystic ovary syndrome	0.000211	0.000432	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—GAB1—polycystic ovary syndrome	0.000208	0.000426	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—NGFR—polycystic ovary syndrome	0.000204	0.000417	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—PLAT—polycystic ovary syndrome	0.000203	0.000415	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—GHRL—polycystic ovary syndrome	0.000203	0.000415	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling by GPCR—POMC—polycystic ovary syndrome	0.000202	0.000414	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—PRL—polycystic ovary syndrome	0.000202	0.000413	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—INSR—polycystic ovary syndrome	0.000199	0.000408	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—PNPLA2—polycystic ovary syndrome	0.000196	0.000401	CbGpPWpGaD
Hydrocodone—OPRK1—GPCR downstream signaling—POMC—polycystic ovary syndrome	0.000195	0.0004	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling by GPCR—AKT2—polycystic ovary syndrome	0.000195	0.000398	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—ATF1—polycystic ovary syndrome	0.000194	0.000396	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—LPCAT2—polycystic ovary syndrome	0.000193	0.000395	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—SUOX—polycystic ovary syndrome	0.000193	0.000395	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—ADRB2—polycystic ovary syndrome	0.000192	0.000392	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—AKR1C3—polycystic ovary syndrome	0.000189	0.000387	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—TCF7L2—polycystic ovary syndrome	0.000189	0.000386	CbGpPWpGaD
Hydrocodone—OPRK1—GPCR downstream signaling—AKT2—polycystic ovary syndrome	0.000188	0.000384	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—TNRC6B—polycystic ovary syndrome	0.000186	0.000381	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—SRD5A1—polycystic ovary syndrome	0.000186	0.00038	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—PGR—polycystic ovary syndrome	0.000184	0.000377	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—ISYNA1—polycystic ovary syndrome	0.00018	0.000368	CbGpPWpGaD
Hydrocodone—CYP3A4—Biological oxidations—POMC—polycystic ovary syndrome	0.000179	0.000366	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—NGFR—polycystic ovary syndrome	0.000179	0.000365	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—GNAS—polycystic ovary syndrome	0.000178	0.000363	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling by GPCR—POMC—polycystic ovary syndrome	0.000177	0.000363	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—STAR—polycystic ovary syndrome	0.000177	0.000362	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—PRL—polycystic ovary syndrome	0.000177	0.000362	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—GHRL—polycystic ovary syndrome	0.000171	0.000351	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—PLAT—polycystic ovary syndrome	0.000171	0.000351	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling by GPCR—AKT2—polycystic ovary syndrome	0.000171	0.000349	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—NCOR1—polycystic ovary syndrome	0.000169	0.000346	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—ADRB2—polycystic ovary syndrome	0.000168	0.000344	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—NRG1—polycystic ovary syndrome	0.000166	0.00034	CbGpPWpGaD
Hydrocodone—OPRM1—GPCR downstream signaling—POMC—polycystic ovary syndrome	0.000165	0.000338	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—ATF1—polycystic ovary syndrome	0.000164	0.000335	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—TCF7L2—polycystic ovary syndrome	0.00016	0.000326	CbGpPWpGaD
Hydrocodone—OPRM1—GPCR downstream signaling—AKT2—polycystic ovary syndrome	0.000159	0.000325	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—HMMR—polycystic ovary syndrome	0.000158	0.000323	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—GNAS—polycystic ovary syndrome	0.000156	0.000319	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—TEAD2—polycystic ovary syndrome	0.000153	0.000313	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—AKR1C2—polycystic ovary syndrome	0.000153	0.000313	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—NGFR—polycystic ovary syndrome	0.000151	0.000309	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—HSD3B1—polycystic ovary syndrome	0.000151	0.000308	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling by GPCR—POMC—polycystic ovary syndrome	0.00015	0.000307	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—PRL—polycystic ovary syndrome	0.00015	0.000306	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—NCOR1—polycystic ovary syndrome	0.000148	0.000304	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—NRG1—polycystic ovary syndrome	0.000146	0.000298	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling by GPCR—AKT2—polycystic ovary syndrome	0.000144	0.000295	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—IRS2—polycystic ovary syndrome	0.000142	0.000291	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—ADRB2—polycystic ovary syndrome	0.000142	0.00029	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—LEP—polycystic ovary syndrome	0.000139	0.000285	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—LHB—polycystic ovary syndrome	0.000137	0.000281	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—HSD3B2—polycystic ovary syndrome	0.000134	0.000275	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—GNAS—polycystic ovary syndrome	0.000132	0.000269	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—AKR1C1—polycystic ovary syndrome	0.00013	0.000266	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—PNPLA2—polycystic ovary syndrome	0.000128	0.000262	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—NCOR1—polycystic ovary syndrome	0.000125	0.000257	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—IRS2—polycystic ovary syndrome	0.000125	0.000255	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—IRS1—polycystic ovary syndrome	0.000124	0.000254	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—NRG1—polycystic ovary syndrome	0.000123	0.000252	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—LEP—polycystic ovary syndrome	0.000122	0.00025	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—SRD5A1—polycystic ovary syndrome	0.000121	0.000248	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—SULT2A1—polycystic ovary syndrome	0.00012	0.000245	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—POMC—polycystic ovary syndrome	0.00012	0.000245	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—INS—polycystic ovary syndrome	0.000119	0.000243	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—RRM2—polycystic ovary syndrome	0.000116	0.000237	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—STAR—polycystic ovary syndrome	0.000116	0.000237	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—IGF1—polycystic ovary syndrome	0.000115	0.000235	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—AKT2—polycystic ovary syndrome	0.000115	0.000235	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—YAP1—polycystic ovary syndrome	0.000112	0.000228	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—SERPINE1—polycystic ovary syndrome	0.000109	0.000223	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—IRS1—polycystic ovary syndrome	0.000109	0.000223	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—NAMPT—polycystic ovary syndrome	0.000107	0.00022	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—CYP11A1—polycystic ovary syndrome	0.000106	0.000217	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—IRS2—polycystic ovary syndrome	0.000105	0.000216	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—POMC—polycystic ovary syndrome	0.000105	0.000215	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—INS—polycystic ovary syndrome	0.000104	0.000213	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—HMMR—polycystic ovary syndrome	0.000103	0.000211	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—LEP—polycystic ovary syndrome	0.000103	0.000211	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—IGF1—polycystic ovary syndrome	0.000101	0.000206	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—AKT2—polycystic ovary syndrome	0.000101	0.000206	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—AKR1C3—polycystic ovary syndrome	0.0001	0.000205	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—CYP17A1—polycystic ovary syndrome	9.85e-05	0.000202	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—HSD3B1—polycystic ovary syndrome	9.84e-05	0.000201	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—SERPINE1—polycystic ovary syndrome	9.58e-05	0.000196	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—IRS1—polycystic ovary syndrome	9.2e-05	0.000188	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—LHB—polycystic ovary syndrome	8.98e-05	0.000184	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—POMC—polycystic ovary syndrome	8.86e-05	0.000181	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—INS—polycystic ovary syndrome	8.81e-05	0.00018	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling by GPCR—IL6—polycystic ovary syndrome	8.8e-05	0.00018	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—HSD3B2—polycystic ovary syndrome	8.77e-05	0.00018	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—IGF1—polycystic ovary syndrome	8.52e-05	0.000174	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—TH—polycystic ovary syndrome	8.52e-05	0.000174	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—AKT2—polycystic ovary syndrome	8.52e-05	0.000174	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—AKR1C1—polycystic ovary syndrome	8.5e-05	0.000174	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—SLC2A4—polycystic ovary syndrome	8.29e-05	0.00017	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—SERPINE1—polycystic ovary syndrome	8.09e-05	0.000166	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—SULT2A1—polycystic ovary syndrome	7.82e-05	0.00016	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—CYP19A1—polycystic ovary syndrome	7.8e-05	0.000159	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling by GPCR—IL6—polycystic ovary syndrome	7.71e-05	0.000158	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—RRM2—polycystic ovary syndrome	7.57e-05	0.000155	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—VEGFA—polycystic ovary syndrome	7.51e-05	0.000154	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—YAP1—polycystic ovary syndrome	7.3e-05	0.000149	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—NAMPT—polycystic ovary syndrome	7.01e-05	0.000144	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—GNAS—polycystic ovary syndrome	6.96e-05	0.000142	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—CYP11A1—polycystic ovary syndrome	6.93e-05	0.000142	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—NCOR1—polycystic ovary syndrome	6.63e-05	0.000136	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—VEGFA—polycystic ovary syndrome	6.59e-05	0.000135	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—AKR1C3—polycystic ovary syndrome	6.54e-05	0.000134	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling by GPCR—IL6—polycystic ovary syndrome	6.52e-05	0.000133	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—CYP17A1—polycystic ovary syndrome	6.44e-05	0.000132	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—CYP1A1—polycystic ovary syndrome	6.28e-05	0.000129	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—MTHFR—polycystic ovary syndrome	5.86e-05	0.00012	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—TH—polycystic ovary syndrome	5.57e-05	0.000114	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—VEGFA—polycystic ovary syndrome	5.57e-05	0.000114	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—SLC2A4—polycystic ovary syndrome	5.42e-05	0.000111	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—IL6—polycystic ovary syndrome	5.2e-05	0.000106	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—CYP19A1—polycystic ovary syndrome	5.1e-05	0.000104	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—PPARG—polycystic ovary syndrome	4.75e-05	9.72e-05	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—POMC—polycystic ovary syndrome	4.68e-05	9.59e-05	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—INS—polycystic ovary syndrome	4.66e-05	9.53e-05	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—IL6—polycystic ovary syndrome	4.56e-05	9.32e-05	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—GNAS—polycystic ovary syndrome	4.55e-05	9.31e-05	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—NCOR1—polycystic ovary syndrome	4.33e-05	8.87e-05	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—CYP1A1—polycystic ovary syndrome	4.11e-05	8.41e-05	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—IL6—polycystic ovary syndrome	3.85e-05	7.88e-05	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—MTHFR—polycystic ovary syndrome	3.83e-05	7.84e-05	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—PPARG—polycystic ovary syndrome	3.11e-05	6.35e-05	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—POMC—polycystic ovary syndrome	3.06e-05	6.27e-05	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—INS—polycystic ovary syndrome	3.05e-05	6.23e-05	CbGpPWpGaD
